Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2012; 18(31): 4150-4155
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4150
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4150
Table 1 Patient characteristics in the two groups of obstructive jaundice
| Benign | Malignant | P value | |
| No. of patients | 51 | 51 | |
| Bilirubin serum level (median and range) (g/dL) | 5.2 (2.12-24.03) 95% CI = 5.0-7.2 | 9.7 (4.07-24.25) 95% CI = 9.6-12.5 | < 0.0001 |
| CA19-9 serum level (median and range) (U/mL) | 36 (2-27019) 95% CI = 0-2.508 | 405 (2.5-62974) 95% CI = 699-6282 | 0.02 |
| > 32 (%) | 28/51 (54.9) | 42/51 (82.3) | 0.003 |
| > 100 (%) | 18/51 (35.3) | 35/51 (68.6) | 0.0007 |
| CRP (median and range) (U/mL) | 6.91 (0.1-30) 95% CI = 4.6-8.3 | 2.97 (0.1-13.2) 95% CI = 2.3-4.1 | 0.0002 |
| > 1.5 (%) | 34/51 (66.6) | 25/51 (49.0) | 0.005 |
| > 5 (%) | 21/51 (41.2) | 7/51 (13.7) | 0.004 |
- Citation: La Greca G, Sofia M, Lombardo R, Latteri S, Ricotta A, Puleo S, Russello D. Adjusting CA19-9 values to predict malignancy in obstructive jaundice: Influence of bilirubin and C-reactive protein. World J Gastroenterol 2012; 18(31): 4150-4155
- URL: https://www.wjgnet.com/1007-9327/full/v18/i31/4150.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i31.4150